Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease
Acute graft-versus-host disease (aGvHD) continues to impact morbidity and mortality after allogeneic stem cell transplantation (allo-SCT). First-line therapy for aGvHD still remains the use of high-dose corticosteroids. Unfortunately, 40–60% of patients with aGvHD exhibit steroid resistance, which i...
Saved in:
Published in | Transfusion medicine and hemotherapy Vol. 46; no. 1; pp. 27 - 34 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.02.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!